Cardinal Health, Inc. – Consensus ‘buy’ rating and 13.0% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Cardinal Health, Inc. which can be found using ticker (CAH) have now 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $129.00 and $95.00 calculating the mean target price we have $114.08. Given that the stocks previous close was at $100.95 and the analysts are correct then there would likely be a percentage uptick in value of 13.0%. There is a 50 day moving average of $100.80 while the 200 day moving average is $101.51. The total market capitalization for the company now stands at 25.35B. The current share price for the company is: $104.09 USD

The potential market cap would be $28,650,396,231 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 46.06, revenue per share of $891.20 and a 2.92% return on assets.

Cardinal Health, Inc. is a globally integrated healthcare services and products company. The Company is focused on providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and solutions. The Company’s segments include Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and patient management.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search